A Curated Platform of Equity & Options Market Intelligence
Select Page

GILD

Search by
TICKER SYMBOL

Gilead Sciences, Inc.

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing

73.25

0.24

(0.329%)

Volume:

8,369,703

52 week range:

69.12 - 86.09

Market Cap:

91.202B

Company Description:

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.